血浆tau与阿尔茨海默病风险人群基底前脑萎缩率相关
本研究纳入276名认知正常但存在阿尔茨海默病风险的老年人,检测基线血浆总tau和神经丝轻链浓度,并随访24个月MRI。结果显示基线血浆总tau较高与基底前脑胆碱能系统年萎缩率较高相关,且独立于β-淀粉样蛋白状态和APOE基因型。
要点
- 基线血浆总tau较高与基底前脑胆碱能系统年萎缩率较高相关。
- 该关联独立于β-淀粉样蛋白负荷和APOE ε4携带状态。
- 基线血浆神经丝轻链、β-淀粉样蛋白负荷和APOE ε4状态不影响基底前脑萎缩率。
核心结论
- 基线血浆总tau浓度升高可能预测阿尔茨海默病风险老年人基底前脑胆碱能系统的结构性萎缩进展。
研究设计与样本
- 本研究为大规模研究,纳入来自单中心INSIGHT-preAD队列的276名认知正常老年人。
- 参与者接受基线血浆总tau和神经丝轻链浓度检测,以及基线和24个月随访MRI扫描。
- 采用线性模型分析血浆神经丝轻链和总tau浓度及其与β-淀粉样蛋白状态和APOE基因型的交互效应对基底前脑胆碱能系统整体及前部(Ch1/2)和后部(Ch4)亚区年萎缩率的影响。
主要发现
- 基线血浆总tau浓度较高与基底前脑胆碱能系统萎缩率较高相关(无影响点模型:n=251,F值=4.6815;p值=0.031)。
- 亚区分析显示Ch1/2亚区年萎缩率(无影响点模型:n=256,F值=3.9535,校正p值=0.047)和Ch4亚区年萎缩率(无影响点模型:n=253,F值=4.9090,校正p值=0.047)结果类似。
- 基线神经丝轻链、β-淀粉样蛋白负荷和APOE ε4携带状态不影响基底前脑胆碱能系统年萎缩率。
临床怎么用
- 在认知正常但存在阿尔茨海默病风险的老年人中,检测基线血浆总tau可能有助于识别基底前脑胆碱能系统萎缩进展风险较高的个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether baseline concentrations of plasma total tau (t-tau) and neurofilament light (NfL) chain proteins are associated with annual percent change (APC) of the basal forebrain cholinergic system (BFCS) in cognitively intact older adults at risk for Alzheimer disease (AD). METHODS: This was a large-scale study of 276 cognitively intact older adults from the monocentric INSIGHT-preAD (Investigation of Alzheimer's Predictors in Subjective Memory Complainers) cohort. Participants underwent baseline assessment of plasma t-tau and NfL concentrations as well as baseline and 24-month follow-up MRI scans. Linear models with and without influential observations (calculated using the Cook distance) were carried out to investigate the effect of plasma NfL and t-tau concentrations, and their interaction effect with β-amyloid status and APOE genotype, on the APC of the whole BFCS and its anterior (Ch1/2) and posterior (Ch4) subdivisions separately. RESULTS: Higher plasma t-tau concentrations at baseline were associated with higher BFCS rate of atrophy (model without influencers: n = 251, F value = 4.6815; p value = 0.031). Subregional analyses showed similar results for both the APC of the Ch1/2 (model without influencers: n = 256, F value = 3.9535, p corrected = 0.047) and Ch4 BFCS sectors (model without influencers: n = 253, F value = 4.9090, p corrected = 0.047). Baseline NfL, β-amyloid load, and APOE ε4 carrier status did not affect APC of the BFCS. CONCLUSION: Increased concentrations of baseline plasma t-tau may predict in vivo structural BFCS atrophy progression in older adults at risk for AD, independently of β-amyloid status and APOE genotype.
引用
- Cavedo E, Lista S, Houot M, et al. Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease. Neurology. 2019. PMID: 31801830. doi:10.1212/WNL.0000000000008696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。